SP-MHCI-0055-2

EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

US$178.10

In stock

Description

About EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

The EBV LMP2 356-364 peptide (FLYALALLL) is a well-defined HLA-A*02:01-restricted epitope derived from Epstein-Barr Virus latent membrane protein 2 (LMP2). It is widely used for the stimulation and detection of EBV-specific CD8+ T cells, supporting precise immune monitoring in infectious disease and oncology research.

The Epstein-Barr Virus (EBV) Latent membrane protein 2 (LMP2) Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Latent membrane protein 2 (LMP2) Peptide, H-FLYALALLL-OH (Uniprot: P13285 aa: 356-364) from JPT is produced under strict quality control and quality management.

EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL - Specifications

  • Peptide sequence: H-FLYALALLL-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Delivery Format: Freeze-dried in plastic vial
  • Application(s): T-cell immunity
  • Condition(s)/Topic(s): Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma, Infectious mononucleosis
  • Standard Delivery Time: approx. 10 days

Visit our webpage for more information on Peptide Tools to Study EBV

The EBV LMP-2 356-364 peptide enables reliable and reproducible analysis of virus-specific immune responses. Its defined sequence FLYALALLL and HLA-A*02:01 restriction ensure accurate antigen presentation, making it a preferred tool for studying CD8+ T cell immunity in EBV-associated conditions.

Applications

  • ELISPOT and FluoroSpot assays
  • Intracellular cytokine staining (ICS)
  • Cytotoxic T lymphocyte (CTL) assays
  • T cell proliferation assays

Why choose this peptide?

  • Proven EBV LMP2 356-364 epitope for immune monitoring
  • Efficient stimulation of EBV-specific CD8+ T cells
  • High purity and strict quality control
  • Suitable for translational research and immunotherapy studies

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?
We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?
Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

References:
Read References with Antigen Peptides

Documentation

Documentation for EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

Properties

Properties of EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma
Layout: Freeze-dried in plastic vial
Organism: Epstein-Barr Virus (EBV)
Protein Name: Latent membrane protein 2 (LMP2)
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No

Further Information to EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

Information Values
Sequence: H-FLYALALLL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote